Michael Matson

Stock Analyst at Needham

(2.62)
# 2,220
Out of 5,012 analysts
23
Total ratings
69.23%
Success rate
11.46%
Average return

Stocks Rated by Michael Matson

Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408$423
Current: $126.89
Upside: +233.36%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $8.59
Upside: +947.73%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $82.70
Upside: -35.91%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $59.31
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $283.28
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $95.90
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $52.15
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $369.24
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $15.09
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $67.73
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $83.82
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $1.49
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $2.75
Upside: -
Upgrades: Buy
Price Target: n/a
Current: $120.95
Upside: -